Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro

Genes Chromosomes and Cancer

Volumn 43, Issue 4, 2005, Pages 315-328

  Williams, Sarah V ^a   Adams, Jacqui ^a   Coulter, Jane ^a   Summersgill, Brenda M ^b   Shipley, Janet ^b   Knowles, Margaret A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

CARCINOMA, TRANSITIONAL CELL; CELL LINE; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 11244351513     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20166     Document Type: Article

References (44)

1. Adams J, Williams SV, Aveyard J, Knowles MA. 2005. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss. Cancer Res 65:66-75.
2. Adelaide J, Huang HE, Murati A, Alsop AE, Orsetti B, Mozziconacci MJ, Popovici C, Ginestier C, Letessier A, Basset C, Courtay-Cahen C, Jacquemier J, Theillet C, Brnbaum D, Edwards PA, Chaffanet M. 2003. A recurrent chromosome translocation break-point in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene. Genes Chromosomes Cancer 37:333-345.
3. Bahia H, Ashman JN, Cawkwell L, Lind M, Monson JR, Drew PJ, Greenman J. 2002. Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. Int J Oncol 20:489-494.
4. Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, Harrison K, Bridge JA, Sorensen P, Thorner P, Squire JA. 2003. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 36:7-16.
5. Bean MA, Pees H, Fogh JE, Grabstald H, Oettgen HF. 1974. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test. Int J Cancer 14:186-197.
6. Bruch J, Wohr G, Bruderlein S, Barbi G, Wolter H, Dixkens C, Mattfeldt T, Moller P, Paiss T, Hautmann R and others. 1999. Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder. Int J Cancer 80:903-910.
7. Christian BJ, Loretz LJ, Oberley TD, Reznikoff CA. 1987. Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res 47:6066-6073.
8. Courtay-Cahen C, Morris JS, Edwards PA. 2000. Chromosome translocations in breast cancer with breakpoints at 8p12. Genomics 66:15-25.
9. Cuthill S, Agarwal P, Sarkar S, Savelieva E, Reznikoff CA. 1999. Dominant genetic alterations in immortalization: role for 20q gain. Genes Chromosomes Cancer 26:304-11.
10. Dalbagni G, Presti JC, Jr., Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C. 1993. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn Mol Pathol 2:4-13.
11. Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PA. 2000. Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 83:1309-1317.
12. Elliott AY, Cleveland P, Cervenka J, Castro AE, Stein N, Hakala TR, Fraley EE. 1974. Characterization of a cell line from human transitional cell cancer of the urinary tract. J Natl Cancer Inst 53:1341-1349.
13. Fadl-Elmula I, Gorunova L, Mandahl N, Elfving P, Lundgren R, Mitelman F, Heim S. 2000. Karyotypic characterization of urinary bladder transitional cell carcinomas. Genes Chromosomes Cancer 29:256-265.
14. Fadl-Elmula I, Kytola S, Pan Y, Lui WO, Derienzo G, Forsberg L, Mandahl N, Gorunova L, Bergerheim US, Heim S, Larsson C. 2001. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis. Int J Cancer 92:824-831.
15. Gibas Z, Gibas L. 1997. Cytogenetics of bladder cancer. Cancer Genet Cytogenet 95:108-115.
16. Grossman HB, Wedemeyer G, Ren L, Wilson GN, Cox B. 1986. Improved growth of human urothelial carcinoma cell cultures. J Urol 136:953-959.
17. Habuchi T, Ogawa O, Kakehi Y, Ogura K, Koshiba M, Sugiyama T, Yoshida O. 1992. Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype. J Urol 148:1595-1599.
18. Habuchi T, Luscombe M, Elder PA, Knowles MA. 1998. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics 48:277-288.
19. Harding MA, Arden KC, Gildea JW, Gildea JJ, Perlman EJ, Viars C, Theodorescu D. 2002. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res 62:6981-6989.
20. Hastings RJ, Franks LM. 1981. Chromosome pattern, growth in agar and tumorigenicity in nude mice of four human bladder carcinoma cell lines. Int J Cancer 27:15-21.
21. Höglund M, Säll T, Heim S, Mitelman F, Mandahl N, Fadl-Elmula I. 2001. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma. Cancer Res 61:8241-8246.
22. Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA. 2004. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 23:2250-2263.
23. ISCN. 1995. An international system for human cytogenetic nomenclature (1995). Basel, Switzerland: Karger.
24. Kyriazis AA, Kyriazis AP, McCombs WB, 3rd, Peterson WD Jr. 1984. Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice. Cancer Res 44:3997-4005.
25. Masters JR. 2000. Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol 1:233-236.
26. Masters JR, Bedford P, Kearney A, Povey S, Franks LM. 1988. Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe. Br J Cancer 57:284-286.
27. Mitelman F, Johansson B, Mertens F 2004. Mitelman Database of Chromosome Aberrations in Cancer, http://cgap.nci.nih.gov/ Chromosomes/Mitelman.
28. O'Toole C, Price ZH, Ohnuki Y, Unsgaard B. 1978. Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 38:64-76.
29. Padilla-Nash HM, Heselmeyer-Haddad K, Wangsa D, Zhang H, Ghadimi BM, Macville M, Augustus M, Schrock E, Hilgenfeld E, Ried T. 2001. Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms. Genes Chromosomes Cancer 30:349-363.
30. Paulie S, Hansson Y, Lundblad ML, Perlmann P. 1983. Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines. Int J Cancer 31:297-303.
31. Perez-Castro AV, Wilson J, Altherr MR. 1997. Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene. Genomics 41:10-16.
32. Rasheed S, Gardner MB, Rongey RW, Nelson-Rees WA, Arrtstein P. 1977. Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst 58:881-890.
33. Reeder JE, Morreale JF, O'Connell MJ, Stadler WM, Olopade OF, Messing EM, Wheeless LL. 1997. Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ Hybridization. J Urol 158:1717-1721.
34. Rigby CG, Franks LMi 1970. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br J Cancer 24:746-754.
35. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. 1996. Multicolor spectral karyotyping of human Chromosomes. Science 273:494-497.
36. Speicher MR, Gwyn Ballard S, Ward DC. 1996. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12:368-375.
37. Strefford JC, Lillington DM, Steggall M, Lane TM, Nouri AM, Young BD, Oliver RT. 2002. Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization. Cancer Genet Cytogenet 135:139-146.
38. Tzeng CC, Liu HS, Li C, Jin YT, Chen RM, Yang WH, Lin JS. 1996. Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan. Anticancer Res 16:1797-1804.
39. Wagner U, Bubendorf L, Gasser TC, Moch H, Gorog JP, Richter J, Mihatsch MJ, Waldman FM, Sauter G. 1997. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. Am J Pathol 151:753-759.
40. Walker MC, Povey S, Parrington JM, Riddle PN, Knuechel R, Masters JR. 1990. Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines. Eur J Cancer 26:742-747.
41. Wang MR, Perissel B, Malet P. 1995. Cytogenetic characterization of a bladder carcinoma cell line by fluorescence in situ hybridization. Cancer Genet Cytogenet 82:170-174.
42. Williams RD. 1980. Human urologic cancer cell lines. Invest Urol 17:359-363.
43. Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA. 2002. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines. Genes Chromosomes Cancer 34:86-96.
44. Wood S, Schertzer M, Drabkin H, Patterson D, Longmire JL, Deaven LL. 1992. Characterization of a human chromosome 8 cosmid library constructed from flow-sorted chromosomes. Cytogenet Cell Genet 59:243-247.